Response to comment on "Dosing implications for liposomal amphotericin B in pregnancy".
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 9, p. 992, doi. 10.1002/phar.2864
- By:
- Publication type:
- Article
Works matching IS 0277-0008 AND VI 43 AND IP 9 AND DT 2023
Results: 12
1
2
Comment on "Dosing implications for liposomal amphotericin B in pregnancy".
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 9, p. 991, doi. 10.1002/phar.2862
- By:
- Publication type:
- Article
3
Fracture risk and opioid use in patients aged 17–64 years: An analysis of administrative claims data.
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 9, p. 913, doi. 10.1002/phar.2849
- By:
- Publication type:
- Article
4
Theophylline for the management of respiratory disorders in adults in the 21st century: A scoping review from the American College of Clinical Pharmacy Pulmonary Practice and Research Network.
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 9, p. 963, doi. 10.1002/phar.2843
- By:
- Publication type:
- Article
5
Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population‐based propensity score‐matched cohort study.
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 9, p. 883, doi. 10.1002/phar.2841
- By:
- Publication type:
- Article
6
Expanded use of sodium‐glucose cotransporter 2 inhibitors: Evidence beyond heart failure with reduced ejection fraction.
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 9, p. 950, doi. 10.1002/phar.2839
- By:
- Publication type:
- Article
7
Evaluation of the efficacy and tolerability of alendronate versus denosumab in kidney transplant patients with reduced bone mineral density.
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 9, p. 904, doi. 10.1002/phar.2838
- By:
- Publication type:
- Article
8
Biomarkers in the intensive care setting: A focus on using procalcitonin and C‐reactive protein to optimize antimicrobial duration of therapy.
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 9, p. 935, doi. 10.1002/phar.2834
- By:
- Publication type:
- Article
9
Patient safety outcomes for continuous infusion vancomycin as outpatient parenteral antimicrobial therapy.
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 9, p. 894, doi. 10.1002/phar.2833
- By:
- Publication type:
- Article
10
Neurokinin‐1 receptor antagonists for the prevention of postoperative nausea and vomiting.
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 9, p. 922, doi. 10.1002/phar.2814
- By:
- Publication type:
- Article
11
Issue Information.
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 9, p. 869, doi. 10.1002/phar.2580
- Publication type:
- Article
12
Effect of cilostazol on preventing paclitaxel‐induced neuropathy in patients with breast cancer: A randomized controlled trial.
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 9, p. 872, doi. 10.1002/phar.2830
- By:
- Publication type:
- Article